scholarly journals Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes

2019 ◽  
Vol 21 (9) ◽  
pp. 2096-2106 ◽  
Author(s):  
Elizabeth M. Garry ◽  
John B. Buse ◽  
Mugdha Gokhale ◽  
Jennifer L. Lund ◽  
Matthew E. Nielsen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bladder Cancer ◽  
Study Design ◽  
Comparative Safety

scholarly journals Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes

2017 ◽  
Vol 20 (1) ◽  
pp. 129-140 ◽  
Author(s):  
Elizabeth M. Garry ◽  
John B. Buse ◽  
Jennifer L. Lund ◽  
Virginia Pate ◽  
Til Stürmer
Keyword(s):  
Type 2 Diabetes ◽  
Bladder Cancer ◽  
Comparative Safety ◽  
Treatment Alternatives

scholarly journals Effect of routinely assessing and addressing depression and diabetes distress using patient-reported outcome measures in improving outcomes among adults with type 2 diabetes: a systematic review protocol

BMJ Open ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. e044888
Author(s):  
Rita McMorrow ◽  
Barbara Hunter ◽  
Christel Hendrieckx ◽  
Dominika Kwasnicka ◽  
Leanne Cussen ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Outcome Measures ◽  
Study Design ◽  
Patient Reported Outcome Measures ◽  
Patient Reported Outcome ◽  
Diabetes Distress ◽  
Controlled Trials ◽  
Patient Reported

IntroductionType 2 diabetes is a global health priority. People with diabetes are more likely to experience mental health problems relative to people without diabetes. Diabetes guidelines recommend assessment of depression and diabetes distress during diabetes care. This systematic review will examine the effect of routinely assessing and addressing depression and diabetes distress using patient-reported outcome measures in improving outcomes among adults with type 2 diabetes.Methods and analysisMEDLINE, Embase, CINAHL Complete, PsycInfo, The Cochrane Library and Cochrane Central Register of Controlled Trials will be searched using a prespecified strategy using a prespecified Population, Intervention, Comparator, Outcomes, Setting and study design strategy. The date range of the search of all databases will be from inception to 3 August 2020. Randomised controlled trials, interrupted time-series studies, prospective and retrospective cohort studies, case–control studies and analytical cross-sectional studies published in peer-reviewed journals in the English language will be included. Two review authors will independently screen abstracts and full texts with disagreements resolved by a third reviewer, if required, using Covidence software. Two reviewers will undertake risk of bias assessment using checklists appropriate to study design. Data will be extracted using prespecified template. A narrative synthesis will be conducted, with a meta-analysis, if appropriate.Ethics and disseminationEthics approval is not required for this review of published studies. Presentation of results will follow the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidance. Findings will be disseminated via peer-reviewed publication and conference presentations.PROSPERO registration numberCRD42020200246.

Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis

Tumor Biology ◽  
2013 ◽  
Vol 35 (3) ◽  
pp. 2095-2102 ◽  
Author(s):  
Shiyao He ◽  
Yu-hong Tang ◽  
Guobin Zhao ◽  
Xiaolong Yang ◽  
Dehou Wang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bladder Cancer ◽  
Meta Analysis

Comparative Safety and Effectiveness of Sitagliptin in Patients with Type 2 Diabetes and Heart Failure

2013 ◽  
Vol 37 ◽  
pp. S45
Author(s):  
Daniala L. Weir ◽  
Finlay A. Mcalister ◽  
A. Senthilselvan ◽  
Jason R. Dyck ◽  
Jasjeet K. Minhas-Sandhu ◽  
...  
Keyword(s):  
Heart Failure ◽  
Type 2 Diabetes ◽  
Comparative Safety
Sign in / Sign up

Export Citation Format

Share Document